Trajectory analysis of metabolomics profiling in liver injured rats using ultra-performance liquid chromatography coupled with mass spectrometry

Analytical Methods

Volumn 5, Issue 19, 2013, Pages 5294-5301

  Zhang, Ai Hua ^a   Sun, Hui ^a   Sun, Wen Jun ^a   Jiao, Guo Zheng ^a   Wang, Xi Jun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY AND MEDICINE; ENDOGENOUS METABOLITES; LOW MOLECULAR WEIGHT; MULTIPLE PERTURBATIONS; NETWORK CONSTRUCTION; PATTERN RECOGNITION METHOD; TIME OF FLIGHT MASS SPECTROMETRY; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACIDS; BIOCHEMISTRY; BIOMOLECULES; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; PATTERN RECOGNITION; PHYSIOLOGY;

TRAJECTORIES;

EID: 84884188287     PISSN: 17599660     EISSN: 17599679     Source Type: Journal    
DOI: 10.1039/c3ay40578h     Document Type: Article

References (25)

1. X. Wang A. Zhang Y. Han P. Wang H. Sun G. Song T. Dong Y. Yuan X. Yuan M. Zhang N. Xie H. Zhang H. Dong W. Dong Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease Mol. Cell. Proteomics 2012 11 8 370 380
2. A. Zhang H. Sun Y. Han Y. Yuan P. Wang G. Song X. Yuan M. Zhang N. Xie X. Wang Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach Analyst 2012 137 18 4200 4208
3. X. Wang H. Wang A. Zhang X. Lu H. Sun H. Dong P. Wang Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis J. Proteome Res. 2012 11 2 1284 1301
4. X. Wang S. Zhang A. Zhang G. Yan X. Wu Y. Han H. Sun Metabolomics study of type 2 diabetes and therapeutic effects of Tianqijiangtang-capsule using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry Anal. Methods 2013 5 2218 2226
5. X. Wang A. Zhang H. Sun Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma Hepatology 2013 57 5 2072 2077
6. A. Zhang H. Sun X. Wu X. Wang Urine metabolomics Clin. Chim. Acta 2012 414 65 69
7. X. Wang A. Zhang H. Sun Future perspectives of Chinese medical formulae: chinmedomics as an effector OMICS 2012 16 7-8 414 421
8. A. Zhang H. Sun P. Wang Y. Han X. Wang Modern analytical techniques in metabolomics analysis Analyst 2012 137 2 293 300
9. H. Dong A. Zhang H. Sun H. Wang X. Lu M. Wang B. Ni X. Wang Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods Mol. BioSyst. 2012 8 4 1206 1221
10. A. Derenne M. Verdonck E. Goormaghtigh The effect of anticancer drugs on seven cell lines monitored by FTIR spectroscopy Analyst 2012 137 14 3255 64
11. X. Wang H. Sun A. Zhang W. Sun P. Wang Z. Wang Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine J. Pharm. Biomed. Anal. 2011 55 5 859 868
12. A. H. Zhang H. Sun S. Qiu X. J. Wang Metabolomics in noninvasive breast cancer Clin. Chim. Acta 2013 424C 3 7
13. X. Wang H. Sun A. Zhang P. Wang Y. Han Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies J. Sep. Sci. 2011 34 24 3451 3459
14. A. Zhang H. Sun X. Wang Power of metabolomics in biomarker discovery and mining mechanisms of obesity Obes. Rev. 2013 14 4 344 349
15. A. Zhang H. Sun P. Wang Y. Han X. Wang Recent and potential developments of biofluid analyses in metabolomics J. Proteomics 2012 75 4 1079 1088
16. T. Shimada T. Nakanishi A. Toyama S. Yamauchi A. Kanzaki H. Fujiwake T. A. Sato M. Ikegawa Potential implications for monitoring serum bile acid profiles in circulation with serum proteome for carbon tetrachloride-induced liver injury/regeneration model in mice J. Proteome Res. 2010 9 9 4490 4500
17. X. Wang H. Sun A. Zhang W. Sun P. Wang Z. Wang Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine J. Pharm. Biomed. Anal. 2011 55 5 859 868
18. D. A. Ouattara J. M. Prot A. Bunescu M. E. Dumas B. Elena-Herrmann E. Leclerc C. Brochot Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells Mol. BioSyst. 2012 8 7 1908 1920
19. X. Wang H. Sun A. Zhang P. Wang Y. Han Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies J. Sep. Sci. 2011 34 24 3451 3459
20. A. Zhang H. Sun G. Yan Y. Han Y. Ye X. Wang Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry Clin. Chim. Acta 2013 418 86 90
21. X. Wang Q. Wang A. Zhang F. Zhang H. Zhang H. Sun H. Cao H. Zhang Metabolomics study of intervention effects of Wen-Xin-Formula using ultra high-performance liquid chromatography/mass spectrometry coupled with pattern recognition approach J. Pharm. Biomed. Anal. 2013 74 22 30
22. A. Zhang H. Sun S. Dou W. Sun X. Wu P. Wang X. Wang Metabolomics study on the hepatoprotective effect of scoparone using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry Analyst 2013 138 1 353 361
23. A. Zhang H. Sun X. Wang Serum metabolomics as a novel diagnostic approach for disease: a systematic review Anal. Bioanal. Chem. 2012 404 4 1239 1245
24. H. Sun A. Zhang G. Yan C. Piao W. Li C. Sun X. Wu X. Li Y. Chen X. Wang Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews Mol. Cell. Proteomics 2013 12 3 710 719
25. A. Zhang H. Sun Y. Han G. Yan X. Wang Urinary Metabolic Biomarker and Pathway Study of Hepatitis B Virus Infected Patients Based on UPLC-MS System PLoS One 2013 8 5 e64381